Arcadia Biosciences, Inc. (RKDA) has 37 open-market insider trades by 19 insiders since 2015. The most active filer is Matthew T. Plavan, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| G. Sperling 2012 Irrevocable Trust No. 3 John | 10% | — | 1 | $8.0M | 2015-05-20 |
| Darby E. Shupp | Dir10% | — | 1 | $8.0M | 2015-05-20 |
| Uday Garg | Dir10% | — | 1 | $3.0M | 2015-05-20 |
| Tej Gujadhur | 10% | — | 1 | $3.0M | 2015-05-20 |
| Dominic Redfern | 10% | — | 1 | $3.0M | 2015-05-20 |
| Eric J. Rey | Dir | — | 3 | $1.1M | 2018-03-23 |
| Kevin Comcowich | Dir | — | 2 | $127K | 2019-09-17 |
| James Richard Reis | Dir | — | 1 | $100K | 2015-10-01 |
| Zhongjin Lu | VP | — | 2 | $59K | 2018-03-23 |
| Matthew T. Plavan | CEO | — | 5 | $31K | 2020-08-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Mark Kawakami | CFO | Buy | $2K | 2025-02-03 |
| Thomas J. Schaefer | CEO | Buy | $1K | 2024-08-01 |
| Thomas J. Schaefer | CFO | Buy | $1K | 2024-02-01 |
| Thomas J. Schaefer | CFO | Buy | $2K | 2023-08-04 |
| Stanley Jacot Jr. | CEO | Buy | $22K | 2023-05-30 |
| Thomas J. Schaefer | CFO | Buy | $161 | 2023-02-01 |
Companies that share insiders with RKDA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Pamela Haley | CFO | Buy | $490 | 2022-08-01 |
| Randall Shultz | CTO | Buy | $2K | 2020-08-03 |
| Matthew T. Plavan | CEO | Buy | $2K | 2020-08-03 |
| Sarah Reiter | Chief Commercial Officer | Buy | $1K | 2020-02-03 |
| Sarah Reiter | Chief Commercial Officer | Buy | $5K | 2019-12-23 |
| Sarah Reiter | Chief Commercial Officer | Buy | $5K | 2019-11-19 |
| Lilian Shackelford Murray | Director | Buy | $21K | 2019-11-18 |
| Matthew T. Plavan | CEO | Buy | $4K | 2019-11-14 |
| Matthew T. Plavan | CEO | Buy | $11K | 2019-09-23 |